Evidence map›Paper›PMID 26156244›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2015

Respiratory Syncytial Virus Utilizes a tRNA Fragment to Suppress Antiviral Responses Through a Novel Targeting Mechanism.

Junfang Deng, Ryan N Ptashkin, Yu Chen, Zhi Cheng, Guangliang Liu, Thien Phan, Xiaoling Deng, Jiehua Zhou, Inhan Lee, Yong Sun Lee and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 175 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  7. Transfer RNA Fragments in Diseases of Sensory Organs.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. The Roles of tRNA-Derived Fragments in Cancer: Updates and Perspectives.International journal of molecular sciences · 2025
    Review
  19. Article
  20. The Impact ofViruses · 2025
    Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Junfang DengDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Ryan N PtashkinmiRcore, Ann Arbor, Michigan, USA.
Yu ChenDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Zhi ChengDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Guangliang LiuDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Thien PhanDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Xiaoling DengDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Jiehua ZhouDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Inhan LeemiRcore, Ann Arbor, Michigan, USA.
Yong Sun LeeDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Xiaoyong BaoDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
The University of Texas Medical Branch at Galveston · USSun Yat-sen University · CNUniversity of Michigan–Ann Arbor · US

Funding

tRNA-derived RNA Fragments (tRFs) and their Functions in Respiratory Syncytial Virus (RSV) InfectionR01AI116812 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BAO, XIAOYONG · 2016 to 2020
$1.9M
Functional Portraits of tRNA-derived Small Non-coding RNAsR21AI113771 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BAO, XIAOYONG · 2015 to 2016
$426k
Characterization of tRNA-derived RNA Fragments (tRFs) in Respiratory Syncytial ViR56AI107033 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BAO, XIAOYONG · 2014 to 2014
$387k
NIAID NIH HHS 1 R56 AI107033-01A1NIAID NIH HHS R01 AI116812NIAID NIH HHS R21 AI113771NIAID NIH HHS R56 AI107033
6 · The paper itself

Abstract

Target identification is highly instructive in defining the biological roles of microRNAs. However, little is known about other small noncoding RNAs; for example, tRNA-derived RNA Fragments (tRFs). Some tRFs exhibit a gene-silencing mechanism distinctly different from that of typical microRNAs. We recently demonstrated that a respiratory syncytial virus (RSV)-induced tRF, called tRF5-GluCTC, promotes RSV replication. RSV is the single most important cause of lower respiratory tract infection in children. By using biochemical screening and bioinformatics analyses, we have identified apolipoprotein E receptor 2 (APOER2) as a target of tRF5-GluCTC. The 3'-portion of tRF5-GluCTC recognizes a target site in the 3'-untranslated region of APOER2 and suppresses its expression. We have also discovered that APOER2 is an anti-RSV protein whose suppression by tRF5-GluCTC promotes RSV replication. Our report represents the first identification of a natural target of a tRF and illustrates how a virus utilizes a host tRF to control a host gene to favor its replication.

Indexed as

Gene SilencingRNA InterferenceBase SequenceBinding SitesCell LineGene Expression RegulationHumansLDL-Receptor Related ProteinsProtein BindingRespiratory Syncytial Virus, HumanRNA, Small UntranslatedRNA, TransferTransfectionViral Structural ProteinsVirus ReplicationLDL-Receptor Related Proteinslow density lipoprotein receptor-related protein 8P protein, human respiratory syncytial virusRNA, Small UntranslatedRNA, TransferViral Structural Proteins

Identifiers

PMID26156244
PMCPMC4817927
OpenAlexW798319868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.